Technosphere® Insulin

DRUG2 trials

Sponsors

Mannkind Corporation

Conditions

AsthmaModerate Chronic Obstructive Pulmonary DiseaseType 1 Diabetes MellitusType 2 DiabetesType 2 Diabetes Mellitus

Phase 3

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

TerminatedNCT00642616

Mannkind CorporationAsthma, Moderate Chronic Obstructive Pulmonary Disease, Type 1 Diabetes Mellitus +1

Start: 2009-03-31End: 2014-11-30Updated: 2017-04-14

Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

CompletedNCT01451398

Mannkind CorporationType 2 Diabetes

Start: 2011-11-30End: 2013-07-31Updated: 2014-10-17